Cart
sales@molnova.com
Rocaglamide
CAS No. 84573-16-0
Rocaglamide( Rocaglamide A | Roc-A )
Catalog No. M24835 CAS No. 84573-16-0
Rocaglamide, isolated from the genus Aglaia, can be used to treat coughs, injuries, asthma, and inflammatory skin diseases. It is a potent inhibitor of NF-κB activation in T-cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 871 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRocaglamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionRocaglamide, isolated from the genus Aglaia, can be used to treat coughs, injuries, asthma, and inflammatory skin diseases. It is a potent inhibitor of NF-κB activation in T-cells.
-
DescriptionRocaglamide, isolated from the genus Aglaia, can be used to treat coughs, injuries, asthma, and inflammatory skin diseases. It is a potent inhibitor of NF-κB activation in T-cells.
-
In Vitro——
-
In Vivo——
-
SynonymsRocaglamide A | Roc-A
-
PathwayAngiogenesis
-
TargetHER/HSP
-
RecptoreIF|HSF1|HSP|NF-κB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number84573-16-0
-
Formula Weight505.56
-
Molecular FormulaC29H31NO7
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mg/mL (19.78 mM);Ethanol:5 mg/mL (9.89 mM)
-
SMILESCN(C)C([C@H]([C@H]([C@]1(c(cc2)ccc2OC)Oc2cc(OC)cc(OC)c2[C@]11O)c2ccccc2)[C@H]1O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Santagata S, et al. Tight coordination of protein translation and heat shock factor 1 activation supports the anabolic malignant state. Science. 2013 Jul 19; 341(6143): 1238303.
molnova catalog
related products
-
DZD9008
DZD9008 is a rationally designed selective, irreversible EGFR/HER2 inhibitor.
-
Pertuzumab
Pertuzumab anti-HER2) a humanized monoclonal antibody and the first in the class of agents called the HER2 dimerization inhibitors impairs the ability of HER2 to bind to other members of the HER family.
-
BI-4142
BI-4142 is an orally active, potent and selective HER2 inhibitor that inhibits cancer cell proliferation, suppresses her2-dependent cell lines and inhibits downstream signalling.
